Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study

This publication has 46 references indexed in Scilit:

• Review article: safety and tolerability of direct‐acting anti‐viral agents in the new era of hepatitis C therapy
  Alimentary Pharmacology & Therapeutics, 2016
• Direct‐acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN‐free treatment and future perspectives
  Liver International, 2016
• Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
  International Journal of Drug Policy, 2015
• Emerging Epidemic of Hepatitis C Virus Infections Among Young Nonurban Persons Who Inject Drugs in the United States, 2006–2012
  Clinical Infectious Diseases, 2014
• Hepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention
  PLOS ONE, 2014
• Can hepatitis C virus infection be eradicated in people who inject drugs?
  Antiviral Research, 2014
• Clinical outcomes in a cohort of anti-hepatitis C virus-positive patients with significant barriers to treatment referred to a Norwegian outpatient clinic
  Scandinavian Journal of Gastroenterology, 2014
• Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
  The Lancet, 2011
• Directly acting antivirals against hepatitis C virus
  Journal of Antimicrobial Chemotherapy, 2011
• The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
  Journal of Hepatology, 2006